Antibiotics resistance of Elizabethkingia Anophelis in patients with ventilator-associated pneumonia at the National Hospital for Tropical Diseases (01/2020 – 05/2024)
Main Article Content
Abstract
The study aimed to describe the antibiotic resistance of Elizabethkingia anophelis in patients with ventilator-associated pneumonia. We conducted a cross-sectional descriptive analysis of bacterial strains isolated from 73 patients diagnosed and treated for ventilator-associated pneumonia associated with Elizabethkingia anophelis at the National Hospital for Tropical Diseases from January 2020 to May 2024. The results showed that 68.5% of patients were 60 years old and older, with a male proportion of 64.4%. 75.4% of patients had at least 1 underlying disease, of which the most common were hypertension and cardiovascular disease (43.7%). Elizabethkingia anophelis bacteria are highly resistant to many antibiotics, specifically ceftazidime is 100%, meropenem is 98.2%, cefepime is 97.7% and imipenem is 96.8%. Bacteria were still sensitive with antibiotics included trimethoprim/sulfamethoxazole (51.6%); norfloxacin (14.3%) and ciprofloxacin (14.0%).
Article Details
Keywords
Ventilator-associated pneumonia, Elizabethkingia anophelis, antibiotic resistance
References
2. Hu S, Lv Y, Xu H, Zheng B, Xiao Y. Biofilm formation and antibiotic sensitivity in Elizabethkingia anophelis. Frontiers in cellular and infection microbiology. 2022; 12:953780. doi:10.3389/fcimb.2022.953780.
3. Huang C, Kuo S, Lin L. Mortality Risk and Antibiotic Therapy for Patients with Infections Caused by Elizabethkingia Species-A Meta-Analysis. Medicina. 2024; 60(9):1529.
4. Choi MH, Kim M, Jeong SJ, et al. Risk Factors for Elizabethkingia Acquisition and Clinical Characteristics of Patients, South Korea. Emerging infectious diseases. Jan 2019; 25(1): 42-51. doi:10.3201/eid2501.171985.
5. Commans F, Hayer J, Do BN, et al. Whole-genome sequence and resistance determinants of four Elizabethkingia anophelis clinical isolates collected in Hanoi, Vietnam. Scientific Reports. 2024/03/27 2024; 14(1): 7241. doi:10.1038/s41598-024-57564-3.
6. Perrin A, Larsonneur E, Nicholson AC, et al. Evolutionary dynamics and genomic features of the Elizabethkingia anophelis 2015 to 2016 Wisconsin outbreak strain. Nature Communications. 2017/05/24 2017; 8(1): 15483. doi:10.1038/ncomms15483.
7. Jiun-Nong Lin, Chung-Hsu Lai, Chih-Hui Yang, Yi-Han Huang. Elizabethkingia Infections in Humans: From Genomics to Clinics. Microorganisms. 2019; 7(9), 295doi: https://doi.org/10.3390/microorganisms7090295.
8. Seong H, Kim JH, Kim JH, et al. Risk Factors for Mortality in Patients with Elizabethkingia Infection and the Clinical Impact of the Antimicrobial Susceptibility Patterns of Elizabethkingia Species. Journal of clinical medicine. May 12 2020; 9(5)doi:10.3390/jcm9051431.
9. Yu-Lin L, Kuan-Ming L, Hui-Lan C, et al. The Evolutionary Trend and Genomic Features of an Emerging Lineage of Elizabethkingia anophelis Strains in Taiwan. Microbiology Spectrum. 2022; 10(1):e01682-21. doi:doi:10.1128/spectrum.01682-21.
10. Lau SKP, Chow W-N, Foo C-H, et al. Elizabethkingia anophelis bacteremia is associated with clinically significant infections and high mortality. Scientific Reports. 2016/05/17 2016; 6(1): 26045. doi:10.1038/srep26045.
11. Cheng YH, Perng CL, Jian MJ, et al. Multicentre study evaluating matrix-assisted laser desorption ionization–time of flight mass spectrometry for identification of clinically isolated Elizabethkingia species and analysis of antimicrobial susceptibility. Clinical Microbiology and Infection. 2019/03/01/ 2019; 25(3): 340-345. doi:https://doi.org/10.1016/j.cmi.2018.04.015.
12. Lin JN, Lai CH, Yang CH, Huang YH. Comparison of Clinical Manifestations, Antimicrobial Susceptibility Patterns, and Mutations of Fluoroquinolone Target Genes between Elizabethkingia meningoseptica and Elizabethkingia anophelis Isolated in Taiwan. Journal of clinical medicine. Dec 11 2018; 7(12)doi:10.3390/jcm7120538.